In contrast, the COX-2 promoter–driven luciferase expression vector showed only background-level activity in the COX-2-negative androgen-sensitive prostate cancer cell line (LnCap) and the COX-2-negative control cells (BT474). The gene discussed is PTGS2; the disease is prostate cancer.